MFSD2A expression levels in brain endothelial cells in AD patients were lower than those in healthy older adults [38], suggesting that insufficient transport of DHA across the BBB is one of the contributing factors underlying lower brain DHA levels in AD [44]. This evidence concerns the gene MFSD2A and Alzheimer disease.